|

Dulaglutide 0.75Mg/0.5Ml Inj Pen Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Pennsylvania1

Indications

  • Abnormal Glucose Tolerance1
  • Pancreatic Insufficiency1
  • Cystic Fibrosis1
  • Diabetes1

Aurora, Colorado1 trial

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Children's Hospital of Colorado

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.